AstraZeneca, Bristol-Myers Squibb: Intellectual Property

(Bloomberg) -- AstraZeneca Plc sued Glenmark Pharmaceuticals Ltd. for seeking U.S. Food and Drug Administration approval to sell a generic version of the breast cancer drug Faslodex.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.